Evidence map›Paper›PMID 40595357›Full record

ArticleCommunications biology2025

Cooperative resistance varies among β-lactamases in E. coli, with some enabling cross-protection and sustained extracellular activity.

Qinqin Wang, Shaodong Wei, Jonas Stenløkke Madsen

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. How social is social resistance?Essays in biochemistry · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qinqin WangSection of Microbiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Shaodong WeiNational Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.
Jonas Stenløkke MadsenSection of Microbiology, Department of Biology, University of Copenhagen, Copenhagen, Denmark. jsmadsen@bio.ku.dk.ORCID http://orcid.org/0000-0003-4830-1796

Funding

Lundbeckfonden (Lundbeck Foundation) R250-2017-1392
6 · The paper itself

Abstract

β-lactamases confer bacteria resistance to β-lactam antibiotics, and interestingly, this protective effect can extend to neighboring susceptible cells. However, knowledge of this cooperative resistance remains limited. Here, we investigated the underlying factors of cooperative resistance to assess commonalities and differences among the highly diverse group of β-lactamases. We first analyzed β-lactamase genes from 2637 Escherichia coli genomes, followed by experimental characterization of seven prevalent β-lactamase genes. Larger plasmids, particularly conjugative ones, commonly encoded β-lactamases. All seven genes had strong wildtype promoters, and plasmid-based expression rescued more susceptible bacteria than chromosomal expression. Cooperative resistance positively correlated with β-lactamase activity and minimal inhibitory concentrations. Cross-protection could be established between different β-lactamase producers, challenging the effectiveness of therapies combining β-lactams. Extracellular activity varied among β-lactamases and, when high, resulted in a legacy resistance effect in the environment. These findings advance our understanding of β-lactam resistance and highlight important implications for antibiotic treatment strategies.

Indexed as

beta-Lactamasesbeta-Lactam ResistanceEscherichia coliAnti-Bacterial Agentsbeta-LactamsEscherichia coli ProteinsMicrobial Sensitivity TestsPlasmidsAnti-Bacterial Agentsbeta-Lactamasesbeta-LactamsEscherichia coli Proteins

Identifiers

PMID40595357
PMCPMC12217783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.